Specify a stock or a cryptocurrency in the search bar to get a summary
MagForce AG
MF6MagForce AG develops advanced nanomedicine for cancer therapies. It offers NanoTherm therapy system, a combination of medical devices for the treatment of solid brain tumors; NanoPlan, a software that stimulates the temperature distribution in the treatment area; NanoTherm, a magnetic ferrofluid; and NanoActivator, a magnetic field generator. MagForce AG was founded in 1997 and is headquartered in Berlin, Germany. Address: Max-Planck-Straße 3, Berlin, Germany, 12489
Analytics
WallStreet Target Price
10.21 EURP/E ratio
–Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures MF6
Dividend Analytics MF6
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History MF6
Stock Valuation MF6
Financials MF6
Results | 2019 | Dynamics |